ResearcherUniversity of CalcuttaActive in the last 2 years

Rudradip Pattanayak

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3597-7423; OpenAlex author ID A5047310140. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Retraction notice to “Porphyrins to restrict progression of pancreatic cancer by stabilizing KRAS G-quadruplex: In silico, in vitro and in vivo validation of a… Co-author DOI 10.1016/j.ejps.2025.107196 ↗
Porphyrins to restrict progression of pancreatic cancer by stabilizing KRAS G-quadruplex: In silico, in vitro and in vivo validation of anticancer strategy. Co-author DOI 10.1016/j.ejps.2018.09.011 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Amlan Kumar Das · 2 shared papers, 2018–2025 · strength 0.34
- Paper Retraction notice to “Porphyrins to restrict progression of pancreatic cancer by stabilizing KRAS G-quadruplex: In sili… DOI 10.1016/j.ejps.2025.107196 ↗
- Paper Porphyrins to restrict progression of pancreatic cancer by stabilizing KRAS G-quadruplex: In silico, in vitro and in vi… DOI 10.1016/j.ejps.2018.09.011 ↗
Maitree Bhattacharyya · 2 shared papers, 2018–2025 · strength 0.34
- Paper Retraction notice to “Porphyrins to restrict progression of pancreatic cancer by stabilizing KRAS G-quadruplex: In sili… DOI 10.1016/j.ejps.2025.107196 ↗
- Paper Porphyrins to restrict progression of pancreatic cancer by stabilizing KRAS G-quadruplex: In silico, in vitro and in vi… DOI 10.1016/j.ejps.2018.09.011 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.